|AHFS/Drugs.com||International Drug Names|
|Oral (tablets), IV|
|Bioavailability||5–11% (Tmax = 2 hours)|
|Metabolism||COMT (slow O-methylation)|
|Elimination half-life||~50 minutes (if taken orally)|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||420.499 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Hexoprenaline is a selective β2 adrenergic receptor agonist used in the treatment of asthma. Hexoprenaline is also used in some countries (such as Russia and Switzerland) as a tocolytic agent (i.e., labor suppressant), with the most common trade name being Gynipral.  It is not approved by U.S. FDA.
When used as a tocolytic, hexoprenaline is contraindicated in:
It should be used with caution in people with gestational diabetes.
When concomitantly administered:
|This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.|